Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Preferred Shares (2016 - 2017)

Apyx Medical filings provide 5 years of Preferred Shares readings, the most recent being $1000.0 for Q2 2017.

  • On a quarterly basis, Preferred Shares fell 50.0% to $1000.0 in Q2 2017 year-over-year; TTM through Jun 2017 was $1000.0, a 50.0% decrease, with the full-year FY2016 number at $1000.0, down 50.0% from a year prior.
  • Preferred Shares hit $1000.0 in Q2 2017 for Apyx Medical, roughly flat from $1000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $3.2 million in Q4 2014 to a low of $1000.0 in Q4 2016.
  • Median Preferred Shares over the past 5 years was $2000.0 (2015), compared with a mean of $645769.2.
  • Biggest five-year swings in Preferred Shares: soared 41.21% in 2014 and later plummeted 99.94% in 2015.
  • Apyx Medical's Preferred Shares stood at $2.3 million in 2013, then skyrocketed by 41.21% to $3.2 million in 2014, then plummeted by 99.94% to $2000.0 in 2015, then crashed by 50.0% to $1000.0 in 2016, then changed by 0.0% to $1000.0 in 2017.
  • The last three reported values for Preferred Shares were $1000.0 (Q2 2017), $1000.0 (Q1 2017), and $1000.0 (Q4 2016) per Business Quant data.